Page last updated: 2024-09-04

pomalidomide and Hypoxia

pomalidomide has been researched along with Hypoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Chauhan, D; Das, A; Das, DS; Oronsky, B; Ray, A; Richardson, P; Scicinski, J; Song, Y; Tian, Z	1

Other Studies

1 other study(ies) available for pomalidomide and Hypoxia

Article	Year
A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells. Leukemia, 2016, Volume: 30, Issue:11 Topics: Animals; Antineoplastic Agents; Apoptosis; Azetidines; Bortezomib; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance, Neoplasm; Drug Synergism; Epigenomics; Heterografts; Humans; Hypoxia; Mice; Multiple Myeloma; Nitro Compounds; Thalidomide; Ubiquitin Thiolesterase; Ubiquitin-Specific Peptidase 7	2016

Article

Year

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells.

Leukemia, 2016, Volume: 30, Issue:11

Topics: Animals; Antineoplastic Agents; Apoptosis; Azetidines; Bortezomib; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance, Neoplasm; Drug Synergism; Epigenomics; Heterografts; Humans; Hypoxia; Mice; Multiple Myeloma; Nitro Compounds; Thalidomide; Ubiquitin Thiolesterase; Ubiquitin-Specific Peptidase 7

2016